Jaguar Health Inc.
05/06/2026 | Press release | Distributed by Public on 05/06/2026 06:00
Additional Proxy Soliciting Materials (Form DEFA14A)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement |
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ |
Definitive Proxy Statement |
| ☒ |
Definitive Additional Materials |
| ☐ |
Soliciting Material under §240.14a-12 |
JAGUAR HEALTH, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☒ |
No fee required. |
| ☐ |
Fee paid previously with preliminary materials. |
| ☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
JAGUAR HEALTH, INC.
SUPPLEMENT TO THE DEFINITIVE PROXY STATEMENT DATED APRIL 30, 2026
FOR THE 2026 ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON FRIDAY, MAY 22, 2026
This supplement (this "Supplement") amends and supplements the proxy statement of Jaguar Health, Inc. (the "Company"), dated April 30, 2026 (the "Proxy Statement"), filed with the U.S. Securities and Exchange Commission in connection with the Company's 2026 Annual Meeting of Stockholders to be held on May 22, 2026 (the "Annual Meeting").
The Company is filing this Supplement to correct an inadvertent error in the Proxy Statement relating to the meeting date of the Annual Meeting.
In the "Notice of 2026 Annual Meeting of Stockholders" section (the "Notice") of the Proxy Statement, the first paragraph incorrectly referred to Tuesday, August 19, 2025 as the date on which the Annual Meeting will be held.
The correct date of the Annual Meeting is Friday, May 22, 2026, as indicated on the cover page of the Proxy Statement and under the title of the Notice.
Except as specifically supplemented by the information contained herein, all information set forth in the Proxy Statement remains unchanged. From and after the date of this Supplement, all references to the "Proxy Statement" are to the Proxy Statement as supplemented by this Supplement. The Proxy Statement contains important information and this Supplement should be read in conjunction with the Proxy Statement.
Jaguar Health Inc. published this content on May 06, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 06, 2026 at 12:00 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]